WHITHER KETAMINE AS AN ANTIDEPRESSANT: PANACEA OR TOXIN?: Editorial
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Cites
Murrough, J. W., Perez, A. M., Pillemer, S., Stern, J., Parides, M. K., aan het Rot, M., Collins, K. A., Mathew, S. J., Charney, D. S., & Iosifescu, D. V. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.06.022 · Cited by 786 · see citing works
Ketamine and other NMDA antagonists: early clinical trials and possible mechanisms in depression.
Newport, D. J., Carpenter, L. L., McDonald, W. M., Potash, J. B., Tohen, M., Nemeroff, C. B., & The APA Council of Research Task Force on Novel Biomarkers and Treatments (2015) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2015.15040465 · Cited by 598 · see citing works
Self-citationSingh, J. B., Fedgchin, M., Daly, E. J., De Boer, P., Cooper, K., Lim, P., Pinter, C., Murrough, J. W., Sanacora, G., Shelton, R. C., et al. (2016) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2016.16010037 · Cited by 525 · see citing works
Sackeïm, H. A., Prudic, J., Devanand, D. P., Decina, P., KERR, B., & Malitz, S. (1990) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199004000-00004 · Cited by 361 · see citing works
Do the dissociative side effects of ketamine mediate its antidepressant effects?
Luckenbaugh, D. A., Niciu, M. J., Ionescu, D. F., Nolan, N. M., Richards, E. M., Brutsche, N. E., Guevara, S., & Zarate, C. A. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.02.017 · Cited by 283 · see citing works
Belujon, P., & Grace, A. A. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.04.014 · Cited by 225 · see citing works
(2013) · PubMed · Cited by 192 · see citing works
Ketamine elicits sustained antidepressant-like activity via a serotonin-dependent mechanism
Gigliucci, V., O’Dowd, G., Casey, S., Egan, D., Gibney, S., & Harkin, A. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3024-x · Cited by 177 · see citing works
Sanacora, G., & Schatzberg, A. F. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2014.261 · Cited by 160 · see citing works
Self-citationTo use or not to use: an update on licit and illicit ketamine use
Li, J., Kasinather, V. B., Cheung, Zhou, Nurhidayat, Jarlais, D., & Schottenfeld, R. S. (2011) · Substance Abuse and Rehabilitation · doi:10.2147/sar.s15458 · Cited by 149 · see citing works
CYLOSERINE AS AN ANTIDEPRESSANT AGENT
CRANE, G. E. (1959) · American Journal of Psychiatry · doi:10.1176/ajp.115.11.1025 · Cited by 127 · see citing works
Ketamine as a Potential Treatment for Suicidal Ideation: A Systematic Review of the Literature
Reinstatler, L., & Youssef, N. A. (2015) · Drugs in R&D · doi:10.1007/s40268-015-0081-0 · Cited by 120 · see citing works
Glutamate-Based Antidepressants: Preclinical Psychopharmacology
Pilc, A., Wierońska, J. M., & Skolnick, P. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.01.021 · Cited by 116 · see citing works
Potential Risks of Poorly Monitored Ketamine Use in Depression Treatment
Schak, K. M., Voort, J. L. V., Johnson, E. K., Kung, S., Leung, J. G., Rasmussen, K. G., Palmer, B. A., & Frye, M. A. (2016) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2015.15081082 · Cited by 96 · see citing works
Robson, M. J., Elliott, M., Seminerio, M. J., & Matsumoto, R. R. (2011) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2011.08.002 · Cited by 94 · see citing works
The failure of the antidepressant drug discovery process is systemic
Hendrie, C. A., & Pickles, A. R. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881112466185 · Cited by 58 · see citing works
François, J., Grimm, O., Schwarz, A. J., Schweiger, J. I., Haller, L., Risterucci, C., Böhringer, A., Zang, Z., Tost, H., Gilmour, G., et al. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.291 · Cited by 34 · see citing works
Soriano, S. G. (2012) · Critical Care Medicine · doi:10.1097/ccm.0b013e31825ae442 · Cited by 18 · see citing works
Henderson, T. A. (2016) · Neural Regeneration Research · doi:10.4103/1673-5374.177708 · Cited by 13 · see citing works
Opioids in Psychiatric Disorders: Back to the Future?
Schatzberg, A. F. (2015) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2015.15101354 · Cited by 9 · see citing works
Self-citationPipeline for New Antidepressants Flowing Slowly
Yan, J. (2012) · Psychiatric News · doi:10.1176/pn.47.5.psychnews_47_5_1-b · Cited by 4 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Acute and Persistent Withdrawal Syndromes Following Discontinuation of Psychotropic Medications
Cosci, F., & Chouinard, G. (2020) · Psychotherapy and Psychosomatics · doi:10.1159/000506868 · Cited by 265 · see citing works
Antidepressant Potential of (R)-Ketamine in Rodent Models: Comparison with (S)-Ketamine
Fukumoto, K., Toki, H., Iijima, M., Hashihayata, T., Yamaguchi, J.-I., Hashimoto, K., & Chaki, S. (2017) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.116.239228 · Cited by 252 · see citing works
Ketamine and Beyond: Investigations into the Potential of Glutamatergic Agents to Treat Depression
Lener, M. S., Kadriu, B., & Zarate, C. A. (2017) · Drugs · doi:10.1007/s40265-017-0702-8 · Cited by 131 · see citing works
McIntyre, R. S., Rodrigues, N. B., Lee, Y., Lipsitz, O., Subramaniapillai, M., Gill, H., Nasri, F., Majeed, A., Lui, L. M. W., Senyk, O., et al. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.05.088 · Cited by 110 · see citing works
Real‐world effectiveness of repeated ketamine infusions for treatment‐resistant bipolar depression
Fancy, F., Rodrigues, N. B., Di Vincenzo, J. D., Chau, E. H., Sethi, R., Husain, M. I., Gill, H., Tabassum, A., Mckenzie, A., Phan, L., et al. (2023) · Bipolar Disorders · doi:10.1111/bdi.13284 · Cited by 40 · see citing works
What Is New about New Antidepressants?
Dubovsky, S. L. (2018) · Psychotherapy and Psychosomatics · doi:10.1159/000488945 · Cited by 37 · see citing works
Nemeroff, C. B. (2018) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2018.18010014 · Cited by 19 · see citing works
Self-citation
- Authors
- Newport, D. J., Schatzberg, A. F., & Nemeroff, C. B.
- Affiliations
- University of Miami (US)
- Stanford Medicine (US)
- Corresponding author
- Nemeroff, Charles B.
- Venue
- Depression and Anxiety
- Publisher
- Hindawi Limited
- Published
- 2016-07-26
- Volume
- 33
- Issue
- 8
- Pages
- 685-688
- ISSN
- 1091-4269 (ISSN-L)
- OpenAlex
- W2494806652
- Cited by
- 30
- References
- 21
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 1 · 2023: 3 · 2022: 3 · 2021: 2 · 2020: 6 · 2018: 5 · 2017: 7 · 2016: 1
- FWCI
- 3.51
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- Depression and Anxiety (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Electroconvulsive Therapy Studies
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Keywords
- ketamine, antidepressants, depression, rapid-acting antidepressants, treatment-resistant depression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review